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Synthesis of substituted hydantoins in low melting
mixtures†
Sangram Gore,ab Kiran Chinthapally,a Sundarababu Baskaran*a and
Burkhard Ko¨nig*b
A novel domino synthesis of 1,3,5-trisubstituted hydantoin deri-
vatives has been developed in low melting L-(+)-tartaric acid–DMU
melt mixtures. The functionalized hydantoins are obtained in good
yields from b,c-unsaturated ketoacids and urea under environ-
mentally benign and simple reaction conditions.
The hydantoin moiety is an important structural scaﬀold
found in a number of biologically active compounds.1
Many hydantoin derivatives have been identified as anti-
convulsant, antiulcer, antiarrhythmic, antimuscarinic, antiviral
and antidiabetic agents.2–5 Moreover, hydantoin derivatives
have also been used as antidepressants as well as platelet aggre-
gation inhibitors.6 Aplysinopsin 1, isolated from the sponge
Aplysinopsis reticulata (Dictyoceartida), exhibits cytotoxicity
against cancer cells and shows ability to aﬀect neurotransmitters
(Fig. 1).7 The spirocyclic hydantoin 2 is a small molecule antagonist
of LFA-1 (lymphocyte function-associated antigen-1).8 Phenytoin (3)
is used in the treatment of epilepsy, whereas nitrofurantoin is an
antimicrobial agent.9a Very recently, GLPG0492 4 has been found to
be a potent partial agonist of the human androgen receptor.9b In
addition, hydantoin dantrolene 5 is a skeletal muscle relaxant.9c,d
Herbicides, such as (+)-hydantocidin, also contain the hydantoin
moiety as an integral part of their structure.10 Moreover, sub-
stituted hydantoins are valuable intermediates for the synthesis
of enantiomerically pure aminoacids through dynamic kinetic
resolution.11
Fig. 1 Biologically active hydantoins.
Scheme 1 Synthesis of a 1,3,5-trisubstituted hydantoin derivative.
Fig. 2 ORTEP diagrams of hydantoin derivative 7 (anti-6,7); ellipsoids shown at
30% probability.
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A variety of synthetic methods exist in the literature for the
preparation of hydantoins from diverse starting materials.1
The classic methods for the synthesis of hydantoin include
the Bucherer–Bergs synthesis and the reaction of urea
with carbonyl compounds.12 In particular, the synthesis of
highly substituted hydantoins is accomplished by reacting
N-substituted a-amino acids or their esters with isocyanates.13
Alternative strategies for the synthesis of substituted hydantoins
use transition metal catalyzed reactions,14 Ugi condensation,15a
reaction of a,b-unsaturated carboxylic acids with carbo-
diimide,15b as well as the reaction of a-amino amides with
phosgene.15c
We have established low melting mixtures16a,b based on
renewable resources as alternative reaction media for carrying out
organic transformations.16c–f Recently, we reported the synthesis of
dihydropyrimidinones (DHPM), pyrimidopyrimidinediones
and indoles in L-(+)-tartaric acid–urea melts.17
Herein, we report the first domino synthesis of 1,3,5-tri-
substituted hydantoin from a b,g-unsaturated ketoacid in low
melting mixtures. Thus, b,g-unsaturated ketoacid 6 reacts in a
surprising transformation, upon exposure to L-(+)-tartaric acid–
dimethylurea (DMU) melt conditions, to 1,3,5-trisubstituited
hydantoin derivative 7 in excellent yield with good diastereo-
selectivity (Scheme 1).
The hydantoin derivative was obtained as a mixture of
syn- and anti-diastereomers and the relative stereochemistry
of the aryl and the hydantoin group was found to be anti to each
other (major distereomer). The relative stereochemistry of the
major anti-hydantoin derivative 13 was established using NOE
experiments.18 Structure and relative stereochemistry of the
major anti-6,7 isomer were confirmed using single crystal X-ray
analysis (Fig. 2).19
Various b,g-unsaturated ketoacids derived from electron
rich as well as electron deficient aldehydes were found to react
readily under the melt conditions to furnish the corresponding
substituted hydantoin derivatives in good to excellent yields.19
The b,g-unsaturated ketoacid 10 derived from piperonal
furnished the corresponding hydantoin derivative 11 in very
good yield. Similarly, the b,g-unsaturated ketoacid 16 derived
from sterically demanding aldehydes, such as 2,4-dichloro
benzaldehyde, smoothly gave the corresponding hydantoin
derivative 17 in excellent yield (Table 1).20 A plausible mecha-
nism for the formation of trisubstituted hydantoin derivatives
is depicted in Scheme 2.
Surprisingly, exposure of b,g-unsaturated ketoacid 18,
derived from furfural, to L-(+)-tartaric acid–DMU melt resulted in
the formation of a novel bicyclic alkylidine hydantoin derivative,








1 7 84 2 : 1
2 9 86 2.8 : 1
3 10 85 2.8 : 1
4 6 87 2 : 1
5 5 92 2.4 : 1
6 2.5 85 2.7 : 1
a Reaction conditions: b,g-unsaturated ketoacid (1 mmol) in L-tartaric
acid–DMU melt (1.5 g) at 70 1C. b Isolated yield.
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19 (Scheme 3). The structure and relative stereochemistry of the
bicyclic alkylidine hydantoin derivative 19 were confirmed
using single crystal X-ray analysis (Fig. 3).18 This example is
of particular interest, since a similar alkylidine hydantoin
derivative has been used in the synthesis of the spirocyclic
hydantoin antagonist 2 (Fig. 1).8
In conclusion, we have developed an eﬃcient domino
synthesis of 1,3,5-trisubstituted hydantoins in low melting
mixtures. The substituted hydantoins were obtained in good
yields under mild and environmentally benign reaction condi-
tions. The melt medium serves simultaneously as a solvent, a
catalyst and a reactant. The facile construction of function-
alized hydantoins makes it a suitable protocol for the synthesis
of potentially bioactive compounds.
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